Hm Payson & CO Magenta Therapeutics, Inc. Transaction History

Hm Payson & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.55 - $5.23 $2,565 - $5,261	-1,006 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$4.43 - $8.33 $4,456 - $8,379	1,006 New	1,006 $4,000
Q2 2021 Aug 17, 2021	SELL	$9.76 - $14.15 $13,868 - $20,107	-1,421 Closed	0 $0
Q4 2020 Mar 10, 2021	SELL	$6.1 - $7.94 $2,031 - $2,644	-333 Reduced 18.99%	1,421 $11,000
Q3 2020 Dec 21, 2020	BUY	$6.52 - $8.94 $11,436 - $15,680	1,754 New	1,754 $12,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.